UPDATE: Rigel Pharma (RIGL) Reports Collaboration and License Agreement with Grifols S.A. (GRFS) to Commercialize Fostamatinib Disodium Hexahydrate in Europe and Turkey

January 23, 2019 7:35 AM

(Updated - January 23, 2019 7:36 AM EST)

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) today announced that it has entered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found